Menu
Live News EARNINGS M impact

AIM Outlines Milestones

AIM ImmunoTech outlines upcoming milestones, including DURIPANC primary endpoint analysis expected in December 2026

AIM

AIM ImmunoTech Outlines Upcoming Milestones, Including DURIPANC Primary Endpoint Analysis Expected In December 2026